(Total Views: 394)
Posted On: 12/14/2019 12:48:40 PM
Post# of 145893
Re: crazyjogger925 #12697
Yes, CYDY purchased Pro-140 (now leronlimab) from PGNX for $3.5M and some milestone payments and royalties I believe. Dr. Maddon was the CEO of PGNX and developed Pro-140. I believe he still serves as a consultant for CYDY on occasion and NP has mentioned he has been pleasantly surprised by the mono and other developments of the drug. Additionally, PGNX will receive up to 5% royalty of net sales for 10 years, so Dr. Maddon / PGNX have interests aligned with shareholders to get leronlimab approved.
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.